MoneyWorks4Me

Nutraplus Generic Medicines ceases to be subsidiary of Nutraplus India

13 May 2016 Evaluate

Nutraplus India has transferred its entire stake in its wholly owned subsidiary ‘Nutraplus Generic Medicines & Health Care Products’ to Mukesh Naik and Uday Desai. Due to said transfer, Nutraplus Generic Medicines & Health Care Products (Nutraplus Generic Medicines) ceased to be a subsidiary of Nutraplus India. The company has taken this step pursuant to the members resolution passed at Annual General Meeting dated September 30, 2015.

Nutraplus India was incorporated as a private limited company in February 1990. The company’s manufacturing unit was commissioned to make APIs and intermediates.
 


Nutraplus India Share Price

2.10 0.00 (0.00%)
13-Dec-2021 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: